Cipla
Cipla Limited, a leading global pharmaceutical company headquartered in India, has been a pioneer in the healthcare industry since its establishment in 1935. With a strong presence in over 80 countries, Cipla focuses on developing a wide range of generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter products. Renowned for its commitment to affordable healthcare, Cipla has made significant strides in areas such as respiratory, cardiovascular, and anti-retroviral therapies. The company is distinguished by its innovative approach to drug development and its robust pipeline of products, which cater to diverse therapeutic needs. Cipla's market position is bolstered by its extensive distribution network and strategic partnerships, making it a trusted name in the pharmaceutical sector. With numerous accolades for its contributions to global health, Cipla continues to lead the way in providing high-quality, accessible medicines.
DitchCarbon Score
How does Cipla's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Cipla's score of 47 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cipla's reported carbon emissions
In 2023, Cipla reported significant carbon emissions, with Scope 1 emissions at approximately 35,831,000 kg CO2e and Scope 2 emissions at about 195,777,000 kg CO2e. The company also disclosed substantial Scope 3 emissions, totalling around 4,105,383,000 kg CO2e, which includes various categories such as purchased goods and services, use of sold products, and employee commuting. Cipla has set ambitious climate commitments, aiming for carbon neutrality by December 2025 for its Scope 1 and Scope 2 emissions, particularly in its India manufacturing operations. The company is focusing on enhancing energy efficiency and increasing the use of renewable energy sources, including electricity and biofuels, as part of its long-term strategy. In previous years, Cipla's emissions have shown fluctuations, with Scope 1 emissions peaking at about 236,358,000 kg CO2e in 2019 and reducing to approximately 41,617,000 kg CO2e in 2021. Scope 2 emissions also varied, with a high of about 241,067,000 kg CO2e in 2020, before stabilising in subsequent years. Cipla's commitment to reducing its carbon footprint aligns with industry standards and reflects a proactive approach to addressing climate change, demonstrating its dedication to sustainability and environmental responsibility.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 236,358,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 55,013,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | 00,000,000 | - | - | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cipla is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
